CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30383% above fair value
$6.03−0.24 (-3.83%)
Close on Nov 13, 2026Market cap $301.78MP/E –Yield –
CapsoVision total assets
Total assets on the balance sheet at the end of each period.
CapsoVision's total assets was $32.75M at Sep 30, 2026. For fiscal 2025 it was $18.16M, up 8.1% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.16M | +8.1% |
| FY2024 | Dec 31, 2024 | $16.80M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $32.75M | +27.6% |
| Q2 FY2026 | Jun 30, 2026 | $18.57M | +94.5% |
| Q1 FY2026 | Mar 31, 2026 | $25.95M | +54.4% |
| Q4 FY2025 | Dec 31, 2025 | $18.16M | – |
| Q3 FY2025 | Sep 30, 2025 | $25.66M | – |
| Q2 FY2025 | Jun 30, 2025 | $9.55M | – |
| Q4 FY2024 | Dec 31, 2024 | $16.80M | – |
See a number that looks wrong?